Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on Dec 05, 2018 7:40pm
85 Views
Post# 29072701

RE:If they ran this thru Cormark how can the crooks say

RE:If they ran this thru Cormark how can the crooks say
quietobserver wrote: they paid too much.

Aphria added that one of its advisors, Cormark Securities Inc., provided financial advice and a fairness opinion that said the transaction for the Colombia, Argentina and Jamaica businesses was “fair, from a financial point of view.”

James Kofman, vice-chairman of Cormark Securities and head of its advisory service, told BNN Bloomberg in a phone interview that the firm has a “very rigourous process to review every fairness opinion we give including the one that was given in this transaction. We take the role of providing opinions very seriously and we are confident in the process we have and the opinions we give.”



it is not illegal to overpay for an asset. The only thing that is if the purchase of the asset with company money be efited the directors directly. In this case it did not.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities